Real-World Management of Thyroid Cancer with TRK Inhibitors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.

Related Videos

November 19, 2014

Payer Coverage in Polycythemia Vera

Ken Schaecher, MD, Medical Director of SelectHealth, describes in his opinion how there is no payer coverage issues with patients with polycythemia vera at this time. Supported through funding from Incyte

January 20, 2016

The Evolution of Stem Cells and Developing Therapies

Dr Wainberg and Dr Gerson talk about blocking cancer stem cell pathways and how randomized trials using therapies aimed at these pathways.